Stockreport

Pharvaris N.V. (PHVS) Discusses Topline Data From RAPIDe-3 Phase III Study of Deucrictibant for Hereditary Angioedema Transcript [Seeking Alpha]

Pharvaris N.V. - Ordinary Shares  (PHVS) 
PDF Company Participants Maggie Beller Berndt A. Modig - Co-Founder, CEO & Executive Director Peng Lu - Chief Medical Officer Wim Souverijns - Chief Commercial Offi [Read more]